Early phase clinical trial for imaging tumor acidosis in breast cancer patients using acidoCEST MRI

使用 AcidoCEST MRI 对乳腺癌患者肿瘤酸中毒进行成像的早期临床试验

基本信息

  • 批准号:
    8948796
  • 负责人:
  • 金额:
    $ 34.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-06-19 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): We have developed a non-invasive imaging method that can quantitatively measure the extracellular pH (pHe) in tumors. Our MRI method uses Chemical Exchange Saturation Transfer (CEST) MRI to assess tumor acidosis, termed "acidoCEST MRI". We have recently translated acidoCEST MRI to a clinical 3T MRI scanner, we have tested volunteers with our protocol, we have an approved IRB protocol for our first clinical trial, and we have assembled an exceptionally strong team of investigators to perform our clinical studies. Therefore, all steps are in place to start our clinical trials. For Specific im 1, we propose to correlate tumor pHe in breast cancer patients with tumor subtype and ex vivo correlates of acidosis, hypoxia, and glycolysis. Our rationale is based on our extensive results from our pre-clinical studies that have shown how more aggressive tumor models have a higher tumor acidosis. We have also shown that tumor pHe is correlated with high expression of carbonic anhydrase IX, which is an established biomarker of tumor hypoxia. We will perform acidoCEST MRI scans with breast cancer patients, and obtain ex vivo correlates from resected tissues during their standard care. For Specific Aim 2, we propose to use acidoCEST MRI to monitor the early response to neoadjuvant chemotherapy in breast cancer patients. Our rationale is based on our pre-clinical imaging results that have shown how Everolimus (an mTOR inhibitor) raises tumor pHe in a lymphoma model within 1 day of initiating therapy, and then returns to an acidic state after 7 days of daily treatment, which foreshadowed the temporary tumor growth delay of this drug treatment. We will perform acidoCEST MRI scans before and 4 weeks after initiating neoadjuvant chemotherapy with dose dense doxorubicin-cyclophosphamide followed by paclitaxel. We will correlate initial tumor pHe and the change in tumor pHe with clinical outcome. Based on these results, our DELIVERABLE is an innovative, noninvasive imaging method that can generate parametric maps of tumor pHe, which can be used to improve diagnosis and evaluate early response to chemotherapy for breast cancer patients.
 描述(由申请人提供):我们开发了一种非侵入性成像方法,可以定量测量肿瘤中的细胞外pH值(pHe)。我们的MRI方法使用化学交换饱和转移(CEST)MRI来评估肿瘤酸中毒,称为“acidoCEST MRI”。我们最近将acidoCEST MRI转换为临床3 T MRI扫描仪,我们已经使用我们的方案测试了志愿者,我们的第一次临床试验获得了IRB批准的方案,我们组建了一支非常强大的研究人员团队来进行我们的临床研究。因此,所有步骤都已到位,可以开始我们的临床试验。对于特定的im 1,我们建议将乳腺癌患者的肿瘤pHe与肿瘤亚型和酸中毒、缺氧和糖酵解的离体相关性相关联。我们的理由是基于我们临床前研究的广泛结果,这些研究表明更具侵袭性的肿瘤模型具有更高的肿瘤酸中毒。我们还表明,肿瘤pH与碳酸酐酶IX的高表达相关,碳酸酐酶IX是肿瘤缺氧的既定生物标志物。我们将对乳腺癌患者进行acidoCEST MRI扫描,并在标准护理期间从切除的组织中获得离体相关信息。对于特定目标2,我们建议使用acidoCEST MRI来监测乳腺癌患者对新辅助化疗的早期反应。我们的理由是基于我们的临床前成像结果,这些结果显示依维莫司(一种mTOR抑制剂)如何在开始治疗的1天内提高淋巴瘤模型中的肿瘤pHe,然后在每天治疗7天后恢复到酸性状态,这预示着这种药物治疗的暂时肿瘤生长延迟。我们将在开始新辅助化疗前和4周后进行acidoCEST MRI扫描,新辅助化疗采用剂量密集的多柔比星-环磷酰胺,随后是紫杉醇。我们将初始肿瘤pHe和肿瘤pHe的变化与临床结果相关联。基于这些结果,我们的DELIVERABLE是一种创新的非侵入性成像方法,可以生成肿瘤pHe的参数图,可用于改善诊断和评估乳腺癌患者对化疗的早期反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark David Pagel其他文献

Mark David Pagel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark David Pagel', 18)}}的其他基金

Exploiting Melanin Synthesis to Improve Tumor Detection with Multispectral Optoacoustic Tomography and Optical Guided Surgery
利用多光谱光声断层扫描和光引导手术利用黑色素合成来改善肿瘤检测
  • 批准号:
    9978211
  • 财政年份:
    2020
  • 资助金额:
    $ 34.99万
  • 项目类别:
Exploiting Melanin Synthesis to Improve Tumor Detection with Multispectral Optoacoustic Tomography and Optical Guided Surgery
利用多光谱光声断层扫描和光引导手术利用黑色素合成来改善肿瘤检测
  • 批准号:
    10152589
  • 财政年份:
    2020
  • 资助金额:
    $ 34.99万
  • 项目类别:
Measuring Tumor Acidosis with PET/MRI Contrast Agents
使用 PET/MRI 造影剂测量肿瘤酸中毒
  • 批准号:
    9750458
  • 财政年份:
    2019
  • 资助金额:
    $ 34.99万
  • 项目类别:
Detection of in vivo enzyme activities with CEST MRI
使用 CEST MRI 检测体内酶活性
  • 批准号:
    8495297
  • 财政年份:
    2012
  • 资助金额:
    $ 34.99万
  • 项目类别:
Measuring extracellular pH in pre-clinical tumor models with CEST MRI
使用 CEST MRI 测量临床前肿瘤模型中的细胞外 pH 值
  • 批准号:
    8446309
  • 财政年份:
    2012
  • 资助金额:
    $ 34.99万
  • 项目类别:
Measuring extracellular pH in pre-clinical tumor models with CEST MRI
使用 CEST MRI 测量临床前肿瘤模型中的细胞外 pH 值
  • 批准号:
    8286741
  • 财政年份:
    2012
  • 资助金额:
    $ 34.99万
  • 项目类别:
Detection of in vivo enzyme activities with CEST MRI
使用 CEST MRI 检测体内酶活性
  • 批准号:
    8852091
  • 财政年份:
    2012
  • 资助金额:
    $ 34.99万
  • 项目类别:
Measuring extracellular pH in pre-clinical tumor models with CEST MRI
使用 CEST MRI 测量临床前肿瘤模型中的细胞外 pH 值
  • 批准号:
    8817152
  • 财政年份:
    2012
  • 资助金额:
    $ 34.99万
  • 项目类别:
Detection of in vivo enzyme activities with CEST MRI
使用 CEST MRI 检测体内酶活性
  • 批准号:
    8353415
  • 财政年份:
    2012
  • 资助金额:
    $ 34.99万
  • 项目类别:
Detection of in vivo protease activities using PARACEST MRI contrast agents
使用 PARACEST MRI 造影剂检测体内蛋白酶活性
  • 批准号:
    7451742
  • 财政年份:
    2008
  • 资助金额:
    $ 34.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了